Consistent with the present study, previous studies have shown that AO causes a disturbance in glucose metabolism by decreasing insulin secretion, resulting in hyperglycemia post-stroke, thereby exacerbating stroke outcomes [19]. The gene discussed is INS; the disease is stroke disorder.